Insider Sale Alert: NovoCure Ltd [NVCR] – Is it Time to sell?

In a filing, NovoCure Ltd revealed its Director Stafford Kristin unloaded Company’s shares for reported $17259.0 on Jun 03 ’25. In the deal valued at $17.28 per share,999 shares were sold. As a result of this transaction, Stafford Kristin now holds 3,054 shares worth roughly $36770.159999999996.

Then, LEUNG GABRIEL sold 999 shares, generating $17,297 in total proceeds. Upon selling the shares at $17.31, the Director now owns 81,229 shares.

Before that, Madden Martin J. sold 999 shares. NovoCure Ltd shares valued at $17,176 were divested by the Director at a price of $17.19 per share. As a result of the transaction, Madden Martin J. now holds 18,674 shares, worth roughly $0.22 million.

Wells Fargo downgraded its NovoCure Ltd [NVCR] rating to an Equal weight from a an Overweight in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Evercore ISI also remained covering NVCR and has increased its forecast on December 02, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. H.C. Wainwright revised its rating on October 16, 2024. It rated NVCR as “a Buy” which previously was an “a Neutral”.

Price Performance Review of NVCR

On Friday, NovoCure Ltd [NASDAQ:NVCR] saw its stock fall -3.99% to $12.04. Over the last five days, the stock has lost -24.84%. NovoCure Ltd shares have fallen nearly -35.86% since the year began. Nevertheless, the stocks have fallen -59.60% over the past one year. While a 52-week high of $34.13 was reached on 01/02/25, a 52-week low of $12.46 was recorded on 07/25/25.

Levels Of Support And Resistance For NVCR Stock

The 24-hour chart illustrates a support level at 11.50, which if violated will result in even more drops to 10.95. On the upside, there is a resistance level at 12.66. A further resistance level may holdings at 13.27.

How much short interest is there in NovoCure Ltd?

A steep rise in short interest was recorded in NovoCure Ltd stocks on 2025-07-15, dropping by 17371.0 shares to a total of 4.93 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 4.94 million shares. There was a decline of -0.35%, which implies that there is a negative sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.